124 related articles for article (PubMed ID: 19864122)
1. Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia.
Nilsson BM; Hultman CM; Ekselius L
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):367-72. PubMed ID: 19864122
[TBL] [Abstract][Full Text] [Related]
2. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
Nilsson BM; Hultman CM; Wiesel FA
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
[TBL] [Abstract][Full Text] [Related]
3. The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects.
Schell AM; Dawson ME; Nuechterlein KH; Subotnik KL; Ventura J
Psychophysiology; 2002 Mar; 39(2):124-32. PubMed ID: 12212661
[TBL] [Abstract][Full Text] [Related]
4. Cognition and autonomic function in schizophrenia: inferior cognitive test performance in electrodermal and niacin skin flush non-responders.
Nilsson BM; Holm G; Hultman CM; Ekselius L
Eur Psychiatry; 2015 Jan; 30(1):8-13. PubMed ID: 25169443
[TBL] [Abstract][Full Text] [Related]
5. The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia.
Smesny S; Rosburg T; Klemm S; Riemann S; Baur K; Rudolph N; Grunwald S; Sauer H
J Psychiatr Res; 2004; 38(5):537-43. PubMed ID: 15380405
[TBL] [Abstract][Full Text] [Related]
6. Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
[TBL] [Abstract][Full Text] [Related]
7. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking.
Liu CM; Chang SS; Liao SC; Hwang TJ; Shieh MH; Liu SK; Chen WJ; Hwu HG
Psychiatry Res; 2007 Aug; 152(2-3):181-7. PubMed ID: 17459487
[TBL] [Abstract][Full Text] [Related]
8. The niacin skin flush test in schizophrenia: a replication study.
Puri BK; Easton T; Das I; Kidane L; Richardson AJ
Int J Clin Pract; 2001; 55(6):368-70. PubMed ID: 11501224
[TBL] [Abstract][Full Text] [Related]
9. [The niacin test in schizophrenia].
Weterle R; Rybakowski J
Psychiatr Pol; 1990; 24(2):116-20. PubMed ID: 2084715
[TBL] [Abstract][Full Text] [Related]
10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
11. Electrodermal orienting response and central nervous system dopamine and serotonin activity in schizophrenia.
Ohlund LS; Lindström LH; Ohman A
J Nerv Ment Dis; 1992 May; 180(5):304-13. PubMed ID: 1374792
[TBL] [Abstract][Full Text] [Related]
12. Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives.
Lin SH; Liu CM; Chang SS; Hwu HG; Liu SK; Hwang TJ; Hsieh MH; Guo SC; Chen WJ
Schizophr Bull; 2007 Jan; 33(1):174-82. PubMed ID: 16936284
[TBL] [Abstract][Full Text] [Related]
13. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia.
Smesny S; Klemm S; Stockebrand M; Grunwald S; Gerhard UJ; Rosburg T; Sauer H; Blanz B
Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):79-85. PubMed ID: 17904833
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
15. Electrodermal predictors of functional outcome and negative symptoms in schizophrenia.
Schell AM; Dawson ME; Rissling A; Ventura J; Subotnik KL; Gitlin MJ; Nuechterlein KH
Psychophysiology; 2005 Jul; 42(4):483-92. PubMed ID: 16008777
[TBL] [Abstract][Full Text] [Related]
16. Chaos in schizophrenia associations, reality or metaphor?
Bob P; Susta M; Chladek J; Glaslova K; Palus M
Int J Psychophysiol; 2009 Sep; 73(3):179-85. PubMed ID: 19166884
[TBL] [Abstract][Full Text] [Related]
17. The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients.
Nadalin S; Giacometti J; Jonovska S; Tomljanović D; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 88(2):185-90. PubMed ID: 23219238
[TBL] [Abstract][Full Text] [Related]
18. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
19. Test-retest stability of neuropsychological testing and individual differences in variability in schizophrenia outpatients.
Conway Greig T; Nicholls SS; Wexler BE; Bell MD
Psychiatry Res; 2004 Dec; 129(3):241-7. PubMed ID: 15661317
[TBL] [Abstract][Full Text] [Related]
20. Niacin subsensitivity is associated with functional impairment in schizophrenia.
Messamore E
Schizophr Res; 2012 May; 137(1-3):180-4. PubMed ID: 22445461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
